Literature DB >> 18560804

[Metal-on-metal hybrid hip resurfacing. Development and current state].

M Hoberg1, M J Le Duff, H C Amstutz.   

Abstract

Worldwide the employment of surface replacements using metal-on-metal components as an option, particularly for the young and active patient, has gained broad acceptance. Part of the attraction for hip resurfacing is its conservative nature as a prosthetic solution for hip arthritis. It is anatomical, replicating the normal hip and limb length, preserving proximal femoral bone, and is a truly minimally bone invasive approach with excellent outcome of joint function. The purpose of this article is to show the data of 1,000 Conserve(c) Plus hybrid metal-on-metal prostheses in a consecutive study of 1,140 patients with a follow-up of 5.6 years. The current Kaplan and Meier survival estimates of the prosthesis, using any conversion to total hip replacement as the end point, were 98.1% at 3 years [95% confidence interval (CI): 96.8-98.9%], 96.7% at 4 years (95% CI: 94.8-97.8%), and 95.2% at 5 years (95% CI: 93.0-96.8%). The mean postoperative Harris hip score was 93.3. The current state of metal-on-metal surface replacement is positive. The new generation of hip resurfacing has a lot of improvements. The purpose of this review of the procedure is to point out the definite improvements from earlier designs using polyethylene as well as to highlight the overall results and durability achieved by one surgeon's extensive experience and to assess the results from other series and centers. We also want to point out the areas where further investigation is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560804     DOI: 10.1007/s00132-008-1286-5

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  28 in total

1.  Belgium experience with metal-on-metal surface arthroplasty.

Authors:  Koen A De Smet
Journal:  Orthop Clin North Am       Date:  2005-04       Impact factor: 2.472

2.  The effects of technique changes on aseptic loosening of the femoral component in hip resurfacing. Results of 600 Conserve Plus with a 3 to 9 year follow-up.

Authors:  Harlan C Amstutz; Michel J Le Duff; Patricia A Campbell; Frederick J Dorey
Journal:  J Arthroplasty       Date:  2007-03-28       Impact factor: 4.757

3.  Early results of primary Birmingham hip resurfacings. An independent prospective study of the first 230 hips.

Authors:  D L Back; R Dalziel; D Young; A Shimmin
Journal:  J Bone Joint Surg Br       Date:  2005-03

Review 4.  Hip resurfacing arthroplasty.

Authors:  Michael A Mont; Phillip S Ragland; Gracia Etienne; Thorsten M Seyler; Thomas P Schmalzried
Journal:  J Am Acad Orthop Surg       Date:  2006-08       Impact factor: 3.020

5.  Surface arthroplasty in young patients with hip arthritis secondary to childhood disorders.

Authors:  Harlan C Amstutz; Edwin P Su; Michel J Le Duff
Journal:  Orthop Clin North Am       Date:  2005-04       Impact factor: 2.472

6.  Optimizing patient selection and outcomes with total hip resurfacing.

Authors:  Thomas P Schmalzried; Mauricio Silva; Mylene A de la Rosa; Eui-Sung Choi; Vincent A Fowble
Journal:  Clin Orthop Relat Res       Date:  2005-12       Impact factor: 4.176

7.  [Functional results after surface replacement of the hip: comparison between dysplasia and idiopathic osteoarthritis].

Authors:  A Knecht; W-C Witzleb; T Beichler; K-P Günther
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 May-Jun

8.  Metal-on-metal hybrid surface arthroplasty: two to six-year follow-up study.

Authors:  Harlan C Amstutz; Paul E Beaulé; Frederick J Dorey; Michel J Le Duff; Pat A Campbell; Thomas A Gruen
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

9.  Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis.

Authors:  J Daniel; P B Pynsent; D J W McMinn
Journal:  J Bone Joint Surg Br       Date:  2004-03

10.  Metal-on-metal hip resurfacing for obese patients.

Authors:  Michel J Le Duff; Harlan C Amstutz; Frederick J Dorey
Journal:  J Bone Joint Surg Am       Date:  2007-12       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.